Si-Bone (SIBN) Cash & Equivalents (2017 - 2026)

Si-Bone's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $29.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 29.65% year-over-year to $29.0 million; the TTM figure through Mar 2026 stood at $29.0 million (down 29.65% YoY), while the FY2025 annual figure was $33.5 million, down 4.08% from the prior year.
• Cash & Equivalents was $29.0 million for Q1 2026 at Si-Bone, down from $33.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $110.8 million in Q2 2023 to a low of $18.9 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $34.3 million across 5 years, with a median of $27.8 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents soared 355.67% in 2023, then sank 76.92% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $20.7 million in 2022, then jumped by 60.6% to $33.3 million in 2023, then climbed by 5.04% to $34.9 million in 2024, then fell by 4.08% to $33.5 million in 2025, then slipped by 13.57% to $29.0 million in 2026.
• The last three Cash & Equivalents figures came in at $29.0 million (Q1 2026), $33.5 million (Q4 2025), and $26.5 million (Q3 2025), per Business Quant data.